ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,623Medicare Part D Prescriptions Filled, Including Refills

Rank: 118 out of 1111

$589K Total Retail Price of All Prescriptions

Rank: 156 out of 1111

360 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 360 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 360 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

1% of this provider’s 10,283 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
FUROSEMIDE 566 519 1 6
POTASSIUM CHLORIDE 423 392 2 9
LEVOTHYROXINE SODIUM 385 347 3 3
LISINOPRIL 334 296 4 2
HYDROCODONE-ACETAMINOPHEN 310 245 S3 5 1
DONEPEZIL HCL 267 266 6 25
WARFARIN SODIUM 261 227 7 19
NAMENDA 231 230 8 31
AMLODIPINE BESYLATE 213 196 9 7
POLYETHYLENE GLYCOL 3350 205 163 10 45
GABAPENTIN 187 166 11 10
RANITIDINE HCL 186 172 12 29
SIMVASTATIN 186 181 12 5
CITALOPRAM HBR 185 159 14 14
DIGOXIN 182 150 15 47
OMEPRAZOLE 180 167 16 4
SERTRALINE HCL 156 105 17 24
MIRTAZAPINE 154 154 18 52
FAMOTIDINE 148 134 19 77
METOPROLOL TARTRATE 140 128 20 12
LANTUS 132 128 21 46
METFORMIN HCL 123 114 22 8
MELOXICAM 120 73 23 18
ALBUTEROL SULFATE 118 115 24 136
CYMBALTA 110 101 25 40
FENTANYL 107 107 S2 26 65
DIVALPROEX SODIUM 106 100 27 82
CRESTOR 98 85 28 33
PRAVASTATIN SODIUM 94 82 29 17
LEVETIRACETAM 92 80 30 111
CLONIDINE HCL 90 78 31 42
DIOVAN 88 88 32 51
PAROXETINE HCL 85 73 33 55
ALENDRONATE SODIUM 82 70 34 35
TRAMADOL HCL 82 75 34 13
LOSARTAN POTASSIUM 80 76 36 34
QUETIAPINE FUMARATE 78 78 37 76
TRAZODONE HCL 78 78 37 32
ATORVASTATIN CALCIUM 77 56 39 15
TAMSULOSIN HCL 76 65 40 28
NYSTATIN 75 70 41 151
HYDROCHLOROTHIAZIDE 74 62 42 11
RISPERIDONE 72 65 43 60
CLOPIDOGREL 70 69 44 30
PANTOPRAZOLE SODIUM 69 69 45 50
MUPIROCIN 68 67 46 154
SPIRONOLACTONE 66 46 47 83
EXELON 65 65 48 121
NOVOLOG 65 55 48 104
CARVEDILOL 64 64 50 21
IPRATROPIUM-ALBUTEROL 64 40 50 161
ENALAPRIL MALEATE 64 64 50 56
LOPERAMIDE 63 61 53 165
DIOVAN HCT 62 62 54 94
HUMALOG 61 25 55 202
FLUOXETINE HCL 61 55 55 44
PHENYTOIN SODIUM EXTENDED 60 42 57 126
SUCRALFATE 60 40 57 125
METOPROLOL SUCCINATE 59 56 59 20
AMIODARONE HCL 58 58 60 145
DILTIAZEM 24HR CD 58 58 60 152
LACTULOSE 57 24 62 166
ISOSORBIDE MONONITRATE ER 54 49 63 73
ATENOLOL 51 45 64 22
SPIRIVA 50 41 65 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 20, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.